Dr Shruti Agnihotri Highlights the Importance of Value-Based Neurologic Care for Post–COVID-19 Patients


Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham, discusses how value-based care can help patients who experience neurologic chronic disease states after COVID-19, in addition to patients with conditions like stroke and dementia.

Value-based care is important for patients who experience neurologic issues after COVID-19, as well as patients with stroke and dementia, says Shruti Agnihotri, MD, associate professor at the University of Alabama Birmingham.


What role does value-based care play in neurological conditions?

Value-based care is very important in neurologic conditions—many different neurologic conditions, of course, in things like dementia, strokes—but I think it's also important in our post–COVID-19 patient population. At the heart of what we do so far for our post–COVID-19 patients is managing high blood pressure, diabetes; the chronic conditions, chronic states, which affect how the brain will function for these patients. I think, yes, there is a large role that value-based care or managed care can play in these patient care situations.

Related Videos
Shrilla Banerjee, MD, FRCP
Zachary Cox, PharmD
Seun Ross, PhD
Alicia Donner, Pittsburgh Financial Empowerment Center
lisa kottschade
Nicolas Ferreyros, Community Oncology Alliance
Vikki Walton, MBA, Mercer
dr erin gillaspie
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Related Content
© 2023 MJH Life Sciences
All rights reserved.